Clinical Trials
153 trialsBYQoL-GC
Assistance Publique - Hôpitaux de Paris
PROGAIN
Soonchunhyang University Hospital
CIME
Centre Leon Berard
Laparoscopic Gastrectomy With D2 Lymphadenectomy Combined With Hyperthermic Intraperitoneal Chemotherapy (HIPEC) or Not
The Affiliated Hospital of Qingdao University
KLASS-09
Korea University Guro Hospital
POISE
Ottawa Hospital Research Institute
XELOX for 4 Months Versus 6 Months in Gastric Cancer (LOMAC)
Fudan University
Adjuvant Oxaliplatin Plus S-1 Versus Docetaxel Plus S-1 for Stage III Gastric Cancer
Ruijin Hospital
Robotic vs Laparoscopic Gastrectomy for cT4a Gastric Cancer
The First Affiliated Hospital with Nanjing Medical University
SOP-XH-IRB
Fujian Medical University
IPa-Gastric
Karolinska University Hospital
SURGIGAST
University Hospital, Lille
Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors
University of Pittsburgh
PREACT
Shanghai Cancer Hospital, China
PERISCOPEII
The Netherlands Cancer Institute
Neoadjuvant Cadonilimab Combined With Perioperative Oxaliplatin Plus S1 for Diffuse or Mixed Type of Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma
Lanzhou University Second Hospital
Neo-CRAG
Sun Yat-sen University
Using ctDNA to Guide Treatment Decisions for Stage III Gastric Cancer
The First Affiliated Hospital with Nanjing Medical University
RCT of Gastric ESD With or Without Epineprhine Added Solution
Chinese University of Hong Kong
Neoadjuvant Apatinib Combined With Sintilimab and Perioperative SOX Versus Neoadjuvant Sintilimab Combined With Perioperative SOX for Intestinal Type of Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma
Lanzhou University Second Hospital
TACTIC
Zhejiang University
ICGastr
Ukrainian Society of Clinical Oncology
Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers
Alliance for Clinical Trials in Oncology
RESCUE-GC
Peking University Cancer Hospital & Institute
FLOT5
Krankenhaus Nordwest
PREVENT
Krankenhaus Nordwest
Comparison Partial Versus Total Omentectomy in Minimal Invasive Distal Gastrectomy for cT3/4a Gastric Cancer (KLASS-10)
Gangnam Severance Hospital
POISE
The Canadian College of Naturopathic Medicine
Metronomic Capecitabine in Stage III Gastric Cancer
Fudan University
3D-4K-ICG
Fujian Medical University
CHIMERA
Jagiellonian University
Adjuvant Capecitabine Versus Observation Alone in Curatively Resected Stage IB Gastric Cancer((KCSG ST14-05): CATALYSIS
Asan Medical Center
Compare Adjuvant Chemotherapy of Docetaxel/Capecitabine/Oxliplatin Versus Capecitabine/Oxaliplatin in Advanced Gastric Cancer at Stage IIIb and IV(KCSG ST15-08): TRIUMPH
Asan Medical Center
Comparing Modified XELOX Plus Sintilimab With Standard XELOX Plus Sintilimab in First-line Treatment for HER2-negative Gastric/Gastroesophageal Junction Adenocarcinoma
Sun Yat-sen University
Assessing How the Viscosity of Submucosal Gel Injections Helps With Endoscopic Mucosal Resections
Maimonides Medical Center
SARONG-II
University of Dublin, Trinity College
Randomized Controlled Trial on Effect of Lymph Node Mapping by Indocyanine Green Via Submucosal or Subserosal Injection
Fujian Medical University
SVOSA
Jinling Hospital, China
IGG Using in Laparoscopic Gastrectomy for Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy
Fujian Medical University
Perioperative FLOT vs Adjuvant XELOX for CA Stomach
Chinese University of Hong Kong
Envollizumab Combined With Fruquintinib and SOX Versus SOX for Conversion Therapy in Advanced Gastric Cancer
Fujian Medical University
EPIC-1511
Centre Oscar Lambret
Clinical Outcome of Palliative Surgery After Translational Therapy for Metastatic Gastric Cancer Versus Maintenance Chemotherapy for Metastatic Gastric Cancer
Fujian Medical University
Optimal Duration of Oxaliplatin in Adjuvant XELOX for Gastric Cancer Patients (EXODOX)
Hallym University Medical Center
Albumin-bound Paclitaxel Plus S-1 Versus SOX as First-line Treatment in Advanced or Recurrent Gastric Adenocarcinoma
Huazhong University of Science and Technology
The Comparison of XELOX and EOX in the First-line Treatment of Advanced Gastric Cancer
Fudan University
ARMANI
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Study of Adjuvant Chemotherapy With or Without PD-1 Inhibitors and Chemoradiotherapy in Resected pN3 Gastric (G) or GEJ Adenocarcinoma
Fudan University
GASTRIPEC
Charite University, Berlin, Germany
Triplet Combination of Cytotoxics as First-line Treatment for Metastatic Gastric Cancer
Sixth Affiliated Hospital, Sun Yat-sen University